Cargando…

Treatment options for postmenopausal osteoporosis

Detalles Bibliográficos
Autor principal:	Walsh, Garry M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2012
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3431956/ https://www.ncbi.nlm.nih.gov/pubmed/22956875 http://dx.doi.org/10.2147/TCRM.S36280

Ejemplares similares

Therapeutic Options in the Prevention and Treatment of Postmenopausal Osteoporosis
por: Kamel, Hosam K., et al.
Publicado: (2006)

Lasofoxifene for the prevention and treatment of postmenopausal osteoporosis
por: Lewiecki, E Michael
Publicado: (2009)

Long-Term Treatment of Postmenopausal Osteoporosis
por: Brown, Jacques P.
Publicado: (2021)

Anabolic treatments for osteoporosis in postmenopausal women
por: Hassan, Neelam, et al.
Publicado: (2021)

Botanicals in Postmenopausal Osteoporosis
por: Słupski, Wojciech, et al.
Publicado: (2021)

Emerging treatments for postmenopausal osteoporosis – focus on denosumab
por: Geusens, Piet
Publicado: (2009)

Safety and tolerability of denosumab for the treatment of postmenopausal osteoporosis
por: Lewiecki, E Michael
Publicado: (2011)

Osteoporosis in the aging male: Treatment options
por: Tuck, Stephen P, et al.
Publicado: (2007)

Update on Denosumab Treatment in Postmenopausal Women with Osteoporosis
por: Min, Yong-Ki
Publicado: (2015)

Current treatment options for postmenopausal vaginal atrophy
por: Naumova, Iuliia, et al.
Publicado: (2018)

Bazedoxifene for the prevention of postmenopausal osteoporosis
por: Gennari, Luigi, et al.
Publicado: (2008)

Abaloparatide is an Effective Treatment Option for Postmenopausal Osteoporosis: Review of the Number Needed to Treat Compared with Teriparatide
por: Reginster, Jean-Yves, et al.
Publicado: (2018)

Long-term treatment with bisphosphonates and their safety in postmenopausal osteoporosis
por: Pazianas, Michael, et al.
Publicado: (2010)

Incorporating bazedoxifene into the treatment paradigm for postmenopausal osteoporosis in Japan
por: Ohta, H., et al.
Publicado: (2014)

Postmenopausal Osteoporosis
por: Kamel, Hosem K.
Publicado: (2006)

Intravenous bisphosphonates for postmenopausal osteoporosis
por: Mottaghi, Peyman
Publicado: (2010)

Efficacy and safety of bazedoxifene for postmenopausal osteoporosis
por: Kawate, Hisaya, et al.
Publicado: (2011)

Once-monthly risedronate for postmenopausal osteoporosis
por: Casadei, Kristina, et al.
Publicado: (2010)

Profile of teriparatide in the management of postmenopausal osteoporosis
por: Sikon, Andrea, et al.
Publicado: (2010)

Strontium ranelate in postmenopausal osteoporosis treatment: a critical appraisal
por: Cesareo, Roberto, et al.
Publicado: (2010)

Controversies in the treatment of postmenopausal osteoporosis: How long to treat with bisphosphonates?
por: Bandeira, Francisco, et al.
Publicado: (2020)

New Antiresorptive Therapies for Postmenopausal Osteoporosis
por: Choi, Hee-Jeong
Publicado: (2015)

Intestinal microbiota: a potential target for the treatment of postmenopausal osteoporosis
por: Xu, Xin, et al.
Publicado: (2017)

Sclerostin Inhibition: A Novel Target for the Treatment of Postmenopausal Osteoporosis
por: Aditya, Suruchi, et al.
Publicado: (2021)

Up-to-Date Knowledge on Osteoporosis Treatment Selection in Postmenopausal Women
por: Jeong, Hye Gyeong, et al.
Publicado: (2022)

Patient preference in the management of postmenopausal osteoporosis with bisphosphonates
por: Reginster, Jean-Yves, et al.
Publicado: (2006)

Denosumab: an investigational drug for the management of postmenopausal osteoporosis
por: Lewiecki, E Michael
Publicado: (2008)

Vitamin K(2) Therapy for Postmenopausal Osteoporosis
por: Iwamoto, Jun
Publicado: (2014)

Ibandronate: the first once-monthly oral bisphosphonate for treatment of postmenopausal osteoporosis
por: Bauss, Frieder, et al.
Publicado: (2006)

Long-term safety and efficacy of raloxifene in the prevention and treatment of postmenopausal osteoporosis: an update
por: Messalli, Enrico M, et al.
Publicado: (2010)

Osteoporosis: Pathophysiology and therapeutic options
por: Föger-Samwald, Ursula, et al.
Publicado: (2020)

New insights into treatment of osteoporosis in postmenopausal women
por: Geusens, Piet
Publicado: (2015)

Factors related with osteoporosis treatment in postmenopausal women
por: Rossi, Lia Mara Montagner, et al.
Publicado: (2018)

Denosumab versus romosozumab for postmenopausal osteoporosis treatment
por: Kobayakawa, Tomonori, et al.
Publicado: (2021)

Management of glucocorticoid-induced osteoporosis: prevalence, and emerging treatment options
por: Payer, Juraj, et al.
Publicado: (2010)

Postmenopausal Osteoporosis: The Role of Immune System Cells
por: Faienza, Maria Felicia, et al.
Publicado: (2013)

Whole-body vibration exercise in postmenopausal osteoporosis
por: Weber-Rajek, Magdalena, et al.
Publicado: (2015)

Economic Evaluation of Denosumab for Treatment of Postmenopausal Osteoporosis: A Systematic Review
por: Nargesi, Shahin, et al.
Publicado: (2022)

Risedronate once monthly: a potential new regimen for the treatment of postmenopausal osteoporosis
por: Moro-Álvarez, María J, et al.
Publicado: (2008)

Treatment of postmenopausal osteoporosis, patient perspectives – focus on once yearly zoledronic acid
por: Carmona, Raj, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_2vl7rrhhelfskq22qosjjkf2g5